Back to Search

IRWIN GOLDSTEIN, MD

MD

Urology Physician

NPI: 1972603694Individual

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

MD018057E(PA)

Clinical Trials (2)

2
Linked Trials
0
Recruiting
1
With Results

Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia

NCT03568604COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA

NCT02784613COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Improvements to the Vulva, Vestibule, Urethral Meatus, and Vagina in Women Treated With Ospemifene for Moderate to Severe Dyspareunia: A Prospective Vulvoscopic Pilot Study.
PMID 29678557·Sex Med·2018
8-other
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause.
PMID 28640161·Menopause·2017
2-rct
A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
PMID 27997350·Horm Mol Biol Clin Investig·2017
2-rct
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.
PMID 26725467·Horm Mol Biol Clin Investig·2016
3-trial
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
PMID 26731686·Menopause·2016
3-trial
Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
PMID 26972555·J Steroid Biochem Mol Biol·2016
8-other
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.
PMID 26597311·J Sex Med·2015
2-rct
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone).
PMID 25734980·Menopause·2015
2-rct
Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.
PMID 23984673·Climacteric·2014
2-rct
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
PMID 24774442·J Sex Med·2014
3-trial
Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
PMID 23954500·J Steroid Biochem Mol Biol·2013
2-rct
One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.
PMID 23096251·Menopause·2013
4-observational
Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.
PMID 23361170·Menopause·2013
4-observational
Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders.
PMID 19058785·Biol Psychiatry·2009
8-other
How family history and risk factors for hypertension relate to ambulatory blood pressure in healthy adults.
PMID 18192842·J Hypertens·2008
8-other
A new alpha-galactosyl-binding protein from the mushroom Lyophyllum decastes.
PMID 17904093·Arch Biochem Biophys·2007
8-other
Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents.
PMID 16508884·Semin Respir Crit Care Med·2006
6-review
Ambulatory blood pressure and family history of hypertension in healthy men and women.
PMID 16647620·Am J Hypertens·2006
4-observational
Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders.
PMID 16712803·Biol Psychiatry·2006
4-observational
Prenatal diagnosis of fetal chest lymphangioma.
PMID 17060430·J Ultrasound Med·2006
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
3400 CIVIC CENTER BOULEVARD, WEST PAVILION 3RD FLOOR
PHILADELPHIA, PA 19104

Locations (2)

Practice Location

3400 CIVIC CENTER BOULEVARD, PHILADELPHIA, PA
(215) 662-2891

Practice Location

300 LACKAWANNA AVE STE 200, SCRANTON, PA
(570) 342-7864

Quick Facts

NPI
1972603694
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
2
Clinical Trials
2
Publications
20

Are you this provider?

Claim Your Profile